Pulmonary Alveolar Proteinosis
"Pulmonary Alveolar Proteinosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
Descriptor ID |
D011649
|
MeSH Number(s) |
C08.381.719
|
Concept/Terms |
Pulmonary Alveolar Proteinosis- Pulmonary Alveolar Proteinosis
- Alveolar Proteinosis, Pulmonary
- Proteinosis, Pulmonary Alveolar
- Pulmonary Alveolar Proteinoses
- Alveolar Proteinoses, Pulmonary
- Proteinoses, Pulmonary Alveolar
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Alveolar Proteinosis".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Alveolar Proteinosis".
This graph shows the total number of publications written about "Pulmonary Alveolar Proteinosis" by people in this website by year, and whether "Pulmonary Alveolar Proteinosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 3 | 0 | 3 |
2018 | 3 | 0 | 3 |
2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Alveolar Proteinosis" by people in Profiles.
-
[Pulmonary alveolar proteinosis]. Medicina (B Aires). 2021; 81(2):301-303.
-
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med. 2019 09 05; 381(10):923-932.
-
An atypical cause of dyspnea. Eur J Intern Med. 2019 Oct; 68:e5-e6.
-
[Crazy Paving Pattern of the Lung]. Pneumologie. 2019 Jan; 73(1):49-53.
-
Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses. Respir Res. 2018 Aug 31; 19(1):163.
-
An eleven-year retrospective cross-sectional study on pulmonary alveolar proteinosis. Adv Respir Med. 2018; 86(1):7-12.
-
Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis. Biomark Med. 2018 02; 12(2):151-159.
-
A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis. Ann Am Thorac Soc. 2017 Sep; 14(9):1403-1411.
-
Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolarĀ proteinosis and fibrosis. Eur Respir J. 2017 05; 49(5).
-
Pulmonary alveolar proteinosis associated with fanconi's anemia. Respiration. 1979; 38(3):177-9.